Drug
Heparin, Low-Molecular-Weight clinical trials
- studies test it
- 55
- open now
- 6
- in phase 3
- 19
- first study started
- 1999
Keep track of what changes. Save the Heparin, Low-Molecular-Weight studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
55 studies that test it; most in 2017 (6)
| Year | Studies |
|---|---|
| 1999 | 1 |
| 2000 | 1 |
| 2002 | 1 |
| 2003 | 1 |
| 2005 | 2 |
| 2006 | 3 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 5 |
| 2011 | 2 |
| 2012 | 2 |
| 2013 | 4 |
| 2015 | 1 |
| 2016 | 3 |
| 2017 | 6 |
| 2018 | 3 |
| 2019 | 1 |
| 2020 | 5 |
| 2021 | 4 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 1
- Phase 1
- 3
- Phase 2
- 6
- Phase 3
- 19
- Phase 4
- 15
- No phase
- 15
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 2 · Other 53
Ain Shams University (3) · Mount Sinai Hospital, Canada (2) · University Medical Center Groningen (2) · Azidus Brasil (2) · Suzanne C. Cannegieter, MD PhD (2) · Azienda Ospedaliera Universitaria Policlinico (2) · Shahid Beheshti University of Medical Sciences (2) · Huashan Hospital (1)
Often tested with
Tested in the same studies.
Heparin (4) · Aspirin (3) · Fluorouracil (3) · Tocilizumab (3) · Rivaroxaban (1) · Low-Dose Aspirin (1) · Acetazolamide (1) · Argatroban (1)
Studies
Open first, then newest update. How each study uses Heparin, Low-Molecular-Weight is read from its arms, and is right about nine times in ten.
Testing it · 55
- Adaptive Platform Trial for Personnalisation of Sepsis Treatment in Children and Adults: a Multi-national, Treatable Traits-guided, Adaptive, Exploratory, Bayesian Basket TrialRecruitingPhase 2Assistance Publique - Hôpitaux de ParisNCT06381661Written as Low molecular weight heparin
- Short-term Low-dose Low-molecular-weight Heparin to Prevent Postpartum ThrombosisRecruitingPhase 3Marc BlondonNCT07140211Written as Low-dose low-molecular-weight heparin
- Prevention of Postpartum Venous Thromboembolism in Women at Intermediate RiskRecruitingPhase 4University Hospital, BrestNCT06845423Written as Low molecular weight heparin
- A Study of the Efficacy of Troxerutin in Preventing Thrombotic Events in COVID-19 PatientsRecruitingPhase 1Westlake UniversityNCT06355258Written as troxerutin + low molecular weight heparin
- A Multicenter, Open-Label, Non-Inferiority Randomized Controlled Trial of Postoperative VTE Prevention in Chinese Patients After Colorectal Cancer SurgeryNot yet recruitingNot applicableBeijing Friendship HospitalNCT06583330Written as Low Molecular Weight Heparin (dalteparin)
- Evaluate the Efficacy and Safety of Various Treatment Schemes for Severe Fever With Thrombocytopenia Syndrome(SFTS)RecruitingPhase 4Qin NingNCT05604859Written as Low molecular weight heparin
- Low Molecular Weight hEparin vs. Aspirin Post-partumCompletedNot applicableMount Sinai Hospital, CanadaNCT05058924Written as Prophylactic low molecular weight heparin
- Postoperative Thrombosis Prevention in Patients With CDActive, not recruitingNot applicableHuashan HospitalNCT04486859Written as LMWH/Rivaroxaban
- Reduced Anticoagulation Targets in ECLS (RATE)CompletedPhase 3University Medical Center GroningenNCT04536272Written as LMWH
- Role of Low-Molecular-Weight Heparin in Unexplained Recurrent Pregnancy LossCompletedNot applicableRESnTEC, Institute of ResearchNCT06484634Written as Low molecular weight heparin
- Efficacy and Safety of Short-term Postoperative Anticoagulant Therapy to Prevente Thrombosis in Arterovenous FistulaCompletedNot applicableFirst Affiliated Hospital of Chongqing Medical UniversityNCT04164693Written as Low molecular weight heparin
- PREVENTion of Clot in Orthopaedic TraumaCompletedPhase 3Major Extremity Trauma Research ConsortiumNCT02984384Written as Low Molecular Weight Heparin (LMWH)
- Treatment of Intrauterine Growth Restriction With Low Molecular Heparin.CompletedPhase 3Fundació Sant Joan de DéuNCT03324139Written as Low molecular weight heparin
- anti10a Levels in Women Treated With LMWH in the Postpartum PeriodCompletedPhase 4HaEmek Medical Center, IsraelNCT02856295Written as clexane (LMWH)
- Pharmacodynamics Study of Enoxalow Compared to Clexane in Healthy Subjects After Subcutaneous Single DoseCompletedPhase 1Azidus BrasilNCT01692158Written as Heparin, Low-Molecular-Weight
- Pharmacodynamics Study of Enoxalow Compared to Clexane in Healthy Subjects After Intravenous AdministrationCompletedPhase 1Azidus BrasilNCT01692171Written as Heparin, Low-Molecular-Weight
- Prophylactic Intravitreal 5-Fluorouracil and Heparin to Prevent PVR in High-risk Patients With Retinal Detachment.CompletedPhase 3Universitätsklinikum KölnNCT02834559Written as 5-fluorouracil and low molecular weight heparin
- Ultra Low Doses of Therapy With Radiation Applicated to COVID-19SuspendedNot applicableFundacion GenesisCareNCT04394182Written as Low molecular weight heparin
- Chemoprophylaxis Plus Early AmbulationCompletedPhase 4Shen LeiNCT03862755Written as Chemoprophylaxis with Low Molecular Weight Heparin (LMWH)
- Thromboprophylaxis in Oesophageal Cancer PatientsStatus unknownPhase 4University of AarhusNCT05067153Written as Fragmin 5000 UNT in 0.2 ML Prefilled Syringe
See all 55 studies that test Heparin, Low-Molecular-Weight →
Given in every arm · 13 — Heparin, Low-Molecular-Weight is usual care beside what is tested
- A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung CancerRecruitingPhase 2Janssen Research & Development, LLCNCT05498428Written as Low Molecular Weight Heparin (LMWH)
- Apixaban, Warfarin and Aspirin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy（ESAWAAPT）CompletedPhase 4Northern Jiangsu People's HospitalNCT04645550Written as Low molecular weight heparin
- Apixaban Prevents Portal Vein Thrombosis After Laparoscopic Splenectomy and Azygoportal DisconnectionCompletedNot applicableNorthern Jiangsu People's HospitalNCT05304455Written as subcutaneous Low Molecular Weight Heparin
- Combination of Inhaled DNase, Baricitinib and Tocilizumab in Severe COVID-19Status unknownNot applicableDemocritus University of ThraceNCT05279391Written as Low molecular weight heparin
- Low Dose Anti-inflammatory Radiotherapy for the Treatment of Pneumonia by COVID-19Status unknownNot applicableGrupo de Investigación Clínica en Oncología RadioterapiaNCT04380818Written as Low molecular weight heparin
- Intermittent Pneumatic Compression in Surgical Patients at Extremely-high Risk for Venous ThromboembolismCompletedNot applicablePirogov Russian National Research Medical UniversityNCT03044574Written as LMWH
- Immunosuppressant Regimens for Living Fetuses StudyStatus unknownNot applicableRenJi HospitalNCT03671174Written as low molecular weight heparin
- Warfarin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy and Azygoportal DisconnectionCompletedPhase 4Yangzhou UniversityNCT02247414Written as Low Molecular Weight Heparin
- Cancer Venous Thromboembolism (VTE)CompletedPhase 3Daiichi SankyoNCT02073682Written as Low molecular weight heparin
- Comparative Investigation of Low Molecular Weight (LMW) Heparin/Edoxaban Tosylate (DU176b) Versus (LMW) Heparin/Warfarin in the Treatment of Symptomatic Deep-Vein Blood Clots and/or Lung Blood Clots. (The Edoxaban Hokusai-VTE Study).CompletedPhase 3Daiichi SankyoNCT00986154Written as low molecular weight heparin/unfractionated heparin
- Warfarin Prevents Portal Vein Thrombosis in Liver Cirrhotic Patients With Hypersplenism After Laparoscopic SplenectomyStatus unknownPhase 4Yangzhou UniversityNCT02238444Written as Low Molecular Weight Heparin
- Study of a Novel Thrombectomy Device to Treat Acute Iliofemoral Deep Venous ThrombosisStatus unknownNot applicableXuzhou Medical UniversityNCT02414802Written as low-molecular-weight heparin calcium
- Effects of Exercise in Combination With Epoetin AlfaCompletedNot applicableUniversity of ArkansasNCT00577096Written as Heparin, Low-Molecular-Weight
As the comparator · 15 — what is tested is compared with Heparin, Low-Molecular-Weight
- Delivery and Implementation of a Randomised Crossover Trial on ThrombosisRecruitingNot applicableQueen Mary University of LondonNCT06937372Written as Low molecular weight heparin (LMWH)
- The PARTUM Trial: Postpartum Aspirin to Reduce Thromboembolism Undue MorbidityRecruitingPhase 3University of CalgaryNCT06494878Written as Low-molecular-weight heparin
- Reduced-Dose Apixaban and Rivaroxaban Versus Low-Molecular-Weight Heparin in Patients With Hematologic MalignanciesRecruitingNot applicableMedical University of GdanskNCT07270263Written as low molecular weight heparin (enoxaparin sodium)
- Hip Fracture Surgery Arterial and Venous Thrombotic Events PreventionNot yet recruitingPhase 3McMaster UniversityNCT07228663Written as Low-molecular weight heparin
- A Study of the Safety and Pharmacokinetics of Apixaban Versus Vitamin K Antagonist (VKA) or Low Molecular Weight Heparin (LMWH) in Pediatric Subjects With Congenital or Acquired Heart Disease Requiring AnticoagulationCompletedPhase 2Bristol-Myers SquibbNCT02981472Written as Low Molecular Weight Heparin (LMWH)
- STOPping Anticoagulation for Isolated or Incidental Subsegmental Pulmonary EmbolismStatus unknownPhase 3University of BirminghamNCT04727437Written as Low molecular weight heparin
- Ticagrelor in Post-transplant Patients With Pediatric Hepatic Artery Thrombosis (HAT)Status unknownPhase 3RenJi HospitalNCT04946929Written as Low molecular weight heparin
- AntiPhospholipid Syndrome Low-molecular-weight Heparin Pregnancy Loss Evaluation: The Pilot StudyTerminatedEarly Phase 1Ottawa Hospital Research InstituteNCT03100123Written as Low-molecular-weight heparin
- Apixaban For Thromboprophylaxis In Patients With Acute Spinal Cord InjuryTerminatedPhase 2McMaster UniversityNCT03200613Written as Low molecular weight heparin
- Rivaroxaban Versus Low-molecular-weight Heparin for Preventing Thrombosis in Cancer PatientsCompletedPhase 1/2Capital Medical UniversityNCT03282643Written as Low-molecular-weight heparin
- Rivaroxaban Once Daily Versus Dose-adjusted Vitamin K Antagonist on the Biomarkers in Acute Decompensated Heart Failure and Atrial Fibrillation (ROAD HF-AF)Status unknownPhase 4Yonsei UniversityNCT03490994Written as Warfarin + LMWH
- Cancer Associated Thrombosis, a Pilot Treatment Study Using RivaroxabanCompletedPhase 3Assistance Publique - Hôpitaux de ParisNCT02746185Written as Low-molecular-weight heparin
- Study on Children Henoch-Schönlein Purpura Nephritis With TCM Multistep TreatmentStatus unknownPhase 1/2Henan University of Traditional Chinese MedicineNCT03591471Written as Low Molecular Weight Heparin Calcium Injection
- Tapered Warfarin or Interrupted Warfarin With Heparin Bridging for Pacemaker or Defibrillator ImplantationTerminatedPhase 3McMaster UniversityNCT02094157Written as Bridged regimen Low-molecular-weight heparin
- Low Dose Rt-PA for Acute Normotensive Pulmonary Embolism With RVDStatus unknownPhase 4Beijing Chao Yang HospitalNCT01531829Written as Low Molecular Weight Heparin
Codes
What other systems call Heparin, Low-Molecular-Weight · ClinicalTrials.gg INT007604
- MeSH (NLM) D006495Heparin, Low-Molecular-WeightOne source ClinicalTrials.gov
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D006495 | Heparin, Low-Molecular-Weight | One source ClinicalTrials.gov |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.